CBD and drug tests: what trace THC means for detection windows

If you work in a safety-sensitive role — commercial driving, aviation, certain construction trades, parts of mining and oil-and-gas, federal law enforcement — you have likely been told that the THC limit on your workplace drug test is unforgiving. You may also have been told that taking CBD is a problem. The relationship between Canadian CBD products and drug tests is more specific than that, and worth understanding before you make a purchase decision.

This article describes how the common drug tests work, why most Canadian CBD products contain measurable trace THC, what the phrase “THC-free” on a label is actually claiming, and how to use a Certificate of Analysis to estimate per-dose THC exposure. We are not legal counsel and we do not give medical advice. If your employer has a specific testing policy, that document is the source of truth, not this article.

How workplace drug tests detect cannabis

The standard workplace drug test in Canada looks for THC’s primary metabolite — 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, commonly written as THC-COOH — in urine. The body produces this metabolite when it processes THC, and it accumulates in fat tissue and is released slowly over days to weeks.

The testing protocol is two-stage:

1. Initial immunoassay screen. A cutoff of 50 ng/mL of THC-COOH in urine is the most common threshold for the screen, though some employers use 20 ng/mL for safety-sensitive roles.
2. Confirmatory GC-MS or LC-MS test. If the screen flags a sample, a confirmatory test typically uses a 15 ng/mL cutoff for THC-COOH. The confirmatory result is the legally defensible one.

Detection windows vary by frequency of exposure. The literature reports that a single low-dose exposure may be undetectable at the 50 ng/mL screen within 1–3 days, but chronic daily exposure can produce positive screens for 30+ days because of THC-COOH’s accumulation in fat tissue.

Why Canadian CBD products contain trace THC

Most Canadian-licensed CBD products are derived from full-spectrum or broad-spectrum extracts. A full-spectrum extract retains the cannabinoid profile of the source plant, which includes a small amount of THC by default. Canadian regulation caps the total THC content of a finished CBD product at 1000 mg per package, and the per-mL concentration in a typical full-spectrum oil is a fraction of a milligram.

To put numbers on it: a 30 mL bottle of full-spectrum CBD oil might list 1000 mg of total CBD and a separate THC line on the COA showing 30 mg of total THC across the bottle, or 1 mg per mL. A 1 mL serving of that oil contains roughly 1 mg of THC.

An isolate-based product, by contrast, is processed to remove every cannabinoid except CBD. A properly tested CBD isolate product will show THC below LOD on its COA — meaning the lab’s instrument cannot detect any THC, which is a different statement from “we removed it” or “we don’t think it’s in there.”

What “THC-free” on a label is claiming

“THC-free” is not a regulated phrase in Canada. The phrase can mean any of:

• Below LOD on the COA — the laboratory’s instrument cannot detect THC at the reporting threshold (commonly 0.001% w/w or similar). This is the most-substantiated claim, and the COA verifies it.
• Below a specified numerical limit — the product contains some THC, but less than (for example) 0.03% w/w. This claim is weaker and the actual amount per dose can still register on a sensitive test.
• An unsupported marketing claim — the product was not tested for THC at the precision needed to substantiate the claim. This is the weakest case, and the COA either is not available or doesn’t include a THC-content line.

The verification rule is unambiguous: open the COA, find the cannabinoid potency table, look at the THC row, and compare the value against your own threshold for caution.

Estimating exposure from a label and a COA

If you want to estimate per-serving THC exposure from a Canadian CBD product:

1. Find the total THC content per package on the COA — typically expressed in mg per package or mg per mL.
2. Multiply by your serving size — a common dose is 1 mL of tincture or one capsule.
3. Compare the result to whatever exposure threshold matters for your workplace, recognising that detection thresholds for drug tests are about THC-COOH metabolite concentration in urine, not about ingested THC dose. The relationship between the two is not linear and is influenced by frequency, body composition, and metabolic factors. We do not have a formula for you. Your physician or occupational-health office is the right party to consult.

Practical takeaways for safety-sensitive workers

Three operational facts:

• Full-spectrum and broad-spectrum CBD oils contain measurable trace THC. Whether that matters for your test depends on the test, the cutoff, your frequency of use, and your metabolism.
• Properly tested CBD isolate products show THC below LOD on the COA. This is the lowest-exposure category. It does not guarantee a negative test result — drug tests measure THC-COOH metabolite concentration, and trace cross-contamination during manufacturing is a known industry issue.
• The COA is the document that matters. If a COA is unavailable for a specific lot, the producer cannot substantiate any claim about cannabinoid content, full stop.

If you have a question about a specific lot’s THC content before purchase — for example, you want to confirm that a particular bottle of isolate-based oil shows THC below LOD — email us at hello@honestbotanicals.co with the product name and we will send the relevant COA before you order.